Global Breast Imaging Market Size Is Set For Moderate Growth, To Reach Around USD 8.17 Billion by 2032
The global Breast Imaging Market size accrued earnings worth approximately USD 4.42 Billion in 2023 and is predicted to gain revenue of about USD 8.17 Billion by 2032, is set to record a CAGR of nearly 7.20% over the period from 2024 to 2032.
Breast imaging is an important diagnostic imaging modality for detection of breast cancer, tumors, assessment of breast morphology and other conditions. Development of novel imaging technologies like full-field digital mammography, digital breast tomosynthesis, etc. is due to technological advancements. Also, technological advancements, initiatives taken by government for creating breast cancer awareness, growing research and development funds/grants from government has boosted the growth of breast imaging market.
The breast imaging market growth is driven mainly due to growing prevalence of breast cancer across the globe and increased breast cancer awareness. Also, increase in public and private investments for breast cancer R&D, growing demand for cost effective diagnostic tools, demand for early cancer detection tools and increasing elderly population are factors likely to boost the breast imaging market growth over the forecast period. However, high cost of imaging systems and lack of reimbursement policies may act as restraining factors for the breast imaging market growth in the coming years. Technological advancements are expected to open new growth opportunities for breast imaging market in the coming years. Also, errors in breast cancer screening, radiation dose management, and increasing adoption of refurbished systems may act as challenging factors for the growth of breast imaging market.
The breast imaging market is segmented based on technology and region. Based on technology market is categorized into non-ionizing imaging, ionizing breast imaging, and other imaging technologies and CAD software. Non-ionizing imaging technology segment will exhibit fastest growth over the forecast period due to advantages this technology offers such as better diagnosis with greater anatomical details, high sensitivity and lesser errors. Breast MRI, breast thermography, breast ultrasound and automated whole-breast ultrasound (AWBU) are sub-segments of non-ionizing breast imaging technology. Positron emission tomography-computed tomography (PET-CT), positron emission mammography (PEM), mammography, and molecular breast imaging (MBI) are sub-segments of ionizing breast imaging technology. Other breast imaging technologies segment is sub-segmented into electric impedance tomography, optical imaging, and cone-beam computed tomography (CBCT).
At regional level, North America dominated the global breast imaging market in 2018. This large share is attributed to various factors such as availability of advanced healthcare infrastructure and facilities, government programs to create breast cancer awareness, presence of major players in U.S., and increasing breast cancer prevalence. Europe was second largest market for breast cancer imaging. Market growth in Europe is supported by increasing breast cancer prevalence, increasing aging population, presence of developed health facilities, swift adoption of technologically advanced devices. Asia Pacific region is projected to experience fastest growth in the coming years owing to increasing breast cancer awareness, increasing disposable income and health spending, and favorable government funds to support research and development. Latin America is forecasted to witness moderate growth whereas Middle East and Africa region will experience slow and steady growth in the coming years.
Major players included in the report are
- Philips Healthcare Installation Teams
- Hologic, Inc.
- Siemens Healthineers
- GE HealthCare
- Aurora Imaging g Technology, Inc.
- FUJIFILM Holdings America Corporation
- CMR Institute Of Technology Naviscan Corporation
- Canonical
- Dilon Technologies Inc.
- Delphinus Medical Technologies, Inc.
- seo kub Inc. (Kubtec)
- Planmed Oy
- Micrima Limited
- SuperSonic Imagine
- SonoCiné
The report segment of global breast imaging market as follows:
Global Breast Imaging Market: Technology
- Ionizing Breast Imaging Mammography Positron Emission Tomography-Computed Tomography (PET-CT)Molecular Breast Imaging (MBI)Positron Emission Mammography (PEM)
- Non-ionizing Breast Imaging Breast Ultrasound Breast MRIA utomated Whole-breast Ultrasound (AWBU)Breast the rmography
- Other Breast Imaging Technologies Cone-beam Computed Tomography (CBCT)Electric Impedance Tomography Optical Imaging
- CAD Software
Global Breast Imaging Market: Regional Segment Analysis
- North America U.S.
- EuropeUKFranceGermany
- Asia Pacific China Japan India
- Latin America Brazil
- Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com